270
Views
3
CrossRef citations to date
0
Altmetric
Review Article

The emerging use of brain stimulation treatments for psychiatric disorders

(Professor)
Pages 923-938 | Published online: 02 Nov 2011

References

  • Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:617–627.
  • Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003; 53:649–659.
  • Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996; 19:179–200.
  • Marder SR. An approach to treatment resistance in schizophrenia. Br J Psychiatry 1999; 37:S19–22.
  • Miller G. Is pharma running out of brainy ideas? Science 2010; 329:502–504.
  • Barker AT. An introduction to the basic principles of magnetic nerve stimulation. J Clin Neurophysiol 1991; 8:26–37.
  • Barker AT. The history and basic principles of magnetic nerve stimulation. Electroencephalogr Clin Neurophysiol Suppl 1999; 51:3–21.
  • Fitzgerald PB, Brown TL, Daskalakis ZJ. The application of transcranial magnetic stimulation in psychiatry and neurosciences research. Acta Psychiatr Scand 2002; 105:324–340.
  • Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol 2006; 117:2584–2596.
  • George MS, Wassermann EM, Williams WA . Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995; 6:1853–1856.
  • Pascual-Leone A, Rubio B, Pallardó F, Catalá MD. Rapid-rate transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996; 348:233–237.
  • George MS, Ketter TA, Post RM. Prefrontal cortex dysfunction in clinical depression. Depression 1994; 2:59–72.
  • Fitzgerald PB, Daskalakis ZJ. The effects of repetitive transcranial magnetic stimulation in the treatment of depression. Expert Rev Med Devices 2011; 8:85–95.
  • Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med 2009; 39:65–75.
  • Gross M, Nakamura L, Pascual-Leone A, Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs the earlier rTMS studies. Acta Psychiatr Scand 2007; 116:165–173.
  • O'Reardon JP, Solvason HB, Janicak PG . Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62:1208–1216.
  • George MS, Lisanby SH, Avery D . Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 2010; 67:507–516.
  • Pridmore S, Bruno R, Turnier-Shea Y, Reid P, Rybak M. Comparison of unlimited numbers of rapid transcranial magnetic stimulation (rTMS) and ECT treatment sessions in major depressive episode. Int J Neuropsychopharmacol 2000; 3:129–134.
  • Janicak PG, Dowd SM, Martis B . Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial. Biol Psychiatry 2002; 51:659–667.
  • Grunhaus L, Dannon PN, Schreiber S . Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiatry 2000; 47:314–324.
  • Grunhaus L, Dannon P, Schreiber S. Effects of transcranial magnetic stimulation on severe depression. Similarities with ECT. Biol Psychiatry 1998; 43:S76.
  • Eranti S, Mogg A, Pluck G . A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry 2007; 164:73–81.
  • Rosa MA, Gattaz WF, Pascual-Leone A . Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study. Int J Neuropsychopharmacol 2006; 9:667–676.
  • McLoughlin DM, Mogg A, Eranti S . The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis. Health Technol Assess 2007; 11:1–54.
  • Holtzheimer PE III, McDonald WM, Mufti M . Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety 2010; 27:960–963.
  • Turnier-Shea Y, Bruno R, Pridmore S. Daily and spaced treatment with transcranial magnetic stimulation in major depression: a pilot study. Aust N Z J Psychiatry 2006; 40:759–763.
  • Isenberg K, Downs D, Pierce K . Low frequency rTMS stimulation of the right frontal cortex is as effective as high frequency rTMS stimulation of the left frontal cortex for antidepressant-free, treatment-resistant depressed patients. Ann Clin Psychiatry 2005; 17:153–159.
  • Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Castella A, Kulkarni J. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry 2003; 60:1002–1008.
  • Fitzgerald PB, Hoy K, Daskalakis ZJ, Kulkarni J. A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression. Depress Anxiety 2009; 26:229–234.
  • Fitzgerald PB, Benitez J, de Castella A, Daskalakis ZJ, Brown TL, Kulkarni J. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 2006; 163:88–94.
  • Fitzgerald PB, Hoy K, Gunewardene R . A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression. Psychol Med 2010; 7:1–10.
  • Pallanti S, Bernardi S, Di Rollo A, Antonini S, Quercioli L. Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression? Neuroscience 2010; 167:323–328.
  • Paulus W. Toward establishing a therapeutic window for rTMS by theta burst stimulation. Neuron 2005; 45:181–183.
  • Fitzgerald PB, Hoy K, McQueen S . Priming stimulation enhances the effectiveness of low-frequency right prefrontal cortex transcranial magnetic stimulation in major depression. J Clin Psychopharmacol 2008; 28:52–58.
  • Schonfeldt-Lecuona C, Lefaucheur JP, Cardenas-Morales L, Wolf RC, Kammer T, Herwig U. The value of neuronavigated rTMS for the treatment of depression. Neurophysiol Clin 2010; 40:37–43.
  • Herwig U, Padberg F, Unger J, Spitzer M, Schonfeldt-Lecuona C. Transcranial magnetic stimulation in therapy studies: examination of the reliability of “standard” coil positioning by neuronavigation. Biol Psychiatry 2001; 50:58–61.
  • Fitzgerald PB, Hoy K, McQueen S . A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology 2009; 34:1255–1262.
  • Herwig U, Lampe Y, Juengling FD . Add-on rTMS for treatment of depression: a pilot study using stereotaxic coil-navigation according to PET data. J Psychiatr Res 2003; 37:267–275.
  • Paillere Martinot ML, Galinowski A, Ringuenet D . Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study. Int J Neuropsychopharmacol 2010; 13:45–59.
  • Herbsman T, Avery D, Ramsey D . More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry 2009; 66:509–515.
  • Fitzgerald PB, Maller JJ, Hoy KE, Thompson R, Daskalakis ZJ. Exploring the optimal site for the localization of dorsolateral prefrontal cortex in brain stimulation experiments. Brain Stimul 2009; 2:234–237.
  • Machii K, Cohen D, Ramos-Estebanez C, Pascual-Leone A. Safety of rTMS to non-motor cortical areas in healthy participants and patients. Clin Neurophysiol 2006; 117:455–471.
  • Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol 2008; 11:131–147.
  • Xia G, Gajwani P, Muzina DJ . Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. Int JNeuropsychopharmacol 2008; 11: 119–130.
  • Zwanzger P, Ella R, Keck ME, Rupprecht R, Padberg F. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry 2002; 51:602–603.
  • Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, 5–7 June 1996. Electroencephalogr Clin Neurophysiol 1998; 108:1–16.
  • Zhang X, Liu K, Sun J, Zheng Z. Safety and feasibility of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression during pregnancy. Arch Womens Ment Health 2010; 13:369–370.
  • Croarkin PE, Wall CA, McClintock SM, Kozel FA, Husain MM, Sampson SM. The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. J ECT 2010; 26:323–329.
  • D’Agati D, Bloch Y, Levkovitz Y, Reti I. rTMS for adolescents: safety and efficacy considerations. Psychiatry Res 2010; 177: 280–285.
  • Boggio PS, Fregni F, Bermpohl F . Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression. Mov Disord 2005; 20: 1178–1184.
  • del Olmo MF, Bello O, Cudeiro J. Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinson's disease. Clin Neurophysiol 2007; 118:131–139.
  • Epstein CM, Evatt ML, Funk A . An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's disease. Clin Neurophysiol 2007; 118: 2189–2194.
  • Jorge RE, Moser DJ, Acion L, Robinson RG. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 2008; 65:268–276.
  • Jorge RE, Robinson RG, Tateno A . Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol Psychiatry 2004; 55:398–405.
  • Fitzgerald PB, Hoy KE, Maller JJ . Transcranial magnetic stimulation for depression following traumatic brain injury: a case study. J ECT 2011; 27:38–40.
  • Glue P, Donovan MR, Kolluri S, Emir B. Meta-analysis of relapse prevention antidepressant trials in depressive disorders. Aust N Z J Psychiatry 2010; 44:697–705.
  • Cohen RB, Boggio PS, Fregni F. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depress Anxiety 2009; 26:682–688.
  • Fitzgerald PB, Benitez J, de Castella A, Brown TL, Daskalakis ZJ, Kulkarni J. A naturalistic study of the use of transcranial magnetic stimulation in the treatment of depressive relapse. Aust N Z J Psychiatry 2006; 40:764–768.
  • Demirtas-Tatlidede A, Mechanic-Hamilton D, Press DZ . An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients. J Clin Psychiatry 2008; 69:930–934.
  • O'Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 2005; 66:1524–1528.
  • Li X, Nahas Z, Anderson B, Kozel FA, George MS. Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety 2004; 20:98–100.
  • Fitzgerald PB, Daskalakis ZJ. A review of repetitive transcranial magnetic stimulation use in the treatment of schizophrenia. Can J Psychiatry 2008; 53:567–576.
  • Blumberger DM, Fitzgerald PB, Mulsant BH, Daskalakis ZJ. Repetitive transcranial magnetic stimulation for refractory symptoms in schizophrenia. Curr Opin Psychiatry 2010; 23:85–90.
  • Poulet E, Brunelin J, Bediou B . Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia. Biol Psychiatry 2005; 57:188–191.
  • Lee S-H, Kim W, Chung Y-C . A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett 2005; 376:177–181.
  • Hoffman RE, Hawkins KA, Gueorguieva R . Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry 2003; 60:49–56.
  • Bagati D, Nizamie SH, Prakash R. Effect of augmentatory repetitive transcranial magnetic stimulation on auditory hallucinations in schizophrenia: randomized controlled study. Aust N Z J Psychiatry 2009; 43:386–392.
  • Fitzgerald PB, Benitez J, Brown T . A double-blind sham controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. J Clin Psychopharmacol 2005; 25:358–362.
  • Aleman A, Sommer IE, Kahn RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin Psychiatry 2007; 68:416–421.
  • Buchanan RW, Kreyenbuhl J, Kelly DL . The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull 2010; 36:71–93.
  • Hajak G, Cohrs S, Tergau F, Ziemann U, Paulus W, Ruther E. Sleep and rTMS. Investigating the link between transcranial magnetic stimulation, sleep, and depression. Electroencephalogr Clin Neurophysiol Suppl 1999; 51:315–321.
  • Jin Y, Potkin SG, Kemp AS . Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia. Schizophr Bull 2006; 32:556–561.
  • Prikryl R, Kasparek T, Skotakova S, Ustohal L, Kucerova H, Ceskova E. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophr Res 2007; 95:151–157.
  • Fitzgerald P, Herring S, Hoy K . A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia. Brain Stimul 2008; 1:27–32.
  • Holi MM, Eronen M, Toivonen K, Toivonen P, Marttunen M, Naukkarinen H. Left prefrontal repetitive transcranial magnetic stimulation in schizophrenia. Schizophr Bull 2004; 30:429–434.
  • Mogg A, Purvis R, Eranti S . Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study. Schizophr Res 2007; 93:221–228.
  • Novak T, Horacek J, Mohr P . The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results. Neuro Endocrinol Lett 2006; 27:209–213.
  • Grisaru N, Chudakov B, Yaroslavsky Y, Belmaker RH. Transcranial magnetic stimulation in mania: a controlled study. Am J Psychiatry 1998; 155:1608–1610.
  • Kaptsan A, Yaroslavsky Y, Applebaum J, Belmaker RH, Grisaru N. Right prefrontal TMS versus sham treatment of mania: a controlled study. Bipolar Disord 2003; 5:36–39.
  • Greenberg BD, George MS, Martin JD . Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive–compulsive disorder: a preliminary study. Am J Psychiatry 1997; 154:867–869.
  • Sachdev PS, McBride R, Loo CK, Mitchell PB, Malhi GS, Croker VM. Right versus left prefrontal transcranial magnetic stimulation for obsessive–compulsive disorder: a preliminary investigation. J Clin Psychiatry 2001; 62:981–984.
  • Alonso P, Pujol J, Cardoner N . Right prefrontal repetitive transcranial magnetic stimulation in obsessive–compulsive disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2001; 158:1143–1145.
  • Prasko J, Paskova B, Zalesky R . The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study. Neuro Endocrinol Lett 2006; 27:327–332.
  • Sachdev PS, Loo CK, Mitchell PB, McFarquhar TF, Malhi GS. Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double-blind controlled investigation. Psychol Med 2007; 37:1645–1649.
  • Mansur CG, Myczkowki ML, de Barros Cabral S . Placebo effect after prefrontal magnetic stimulation in the treatment of resistant obsessive–compulsive disorder: a randomized controlled trial. Int J Neuropsychopharmacol 2011 DOI: 10.1017/S14611 45711000599.
  • Grisaru N, Amir M, Cohen H, Kaplan Z. Effect of transcranial magnetic stimulation in posttraumatic stress disorder: a preliminary study. Biol Psychiatry 1998; 44:52–55.
  • Cohen H, Kaplan Z, Kotler M, Kouperman I, Moisa R, Grisaru N. Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2004; 161: 515–524.
  • Rosenberg PB, Mehndiratta RB, Mehndiratta YP, Wamer A, Rosse RB, Balish M. Repetitive transcranial magnetic stimulation treatment of comorbid posttraumatic stress disorder and major depression. J Neuropsychiatry Clin Neurosci 2002; 14:270–276.
  • Mantovani A, Lisanby SH, Pieraccini F, Ulivelli M, Castrogiovanni P, Rossi S. Repetitive transcranial magnetic stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression. J Affect Disord 2007; 102:277–280.
  • Zwanzger P, Minov C, Ella R . Transcranial magnetic stimulation for panic. Am J Psychiatry 2002; 159:315–316.
  • Prasko J, Zalesky R, Bares M . The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study. Neuro Endocrinol Lett 2007; 28:33–38.
  • Camprodon JA, Martinez-Raga J, Alonso-Alonso M, Shih MC, Pascual-Leone A. One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug Alcohol Depend 2007; 86:91–94.
  • Eichhammer P, Johann M, Kharraz A . High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking. J Clin Psychiatry 2003; 64:951–953.
  • Mishra BR, Nizamie SH, Das B, Praharaj SK. Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study. Addiction 2010; 105:49–55.
  • Amiaz R, Levy D, Vainiger D, Grunhaus L, Zangen A. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction 2009; 104:653–660.
  • Rohan M, Parow A, Stoll AL . Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator. Am J Psychiatry 2004; 161:93–98.
  • Carlezon WA Jr, Rohan ML, Mague SD . Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats. Biol Psychiatry 2005; 57:571–576.
  • Volkow ND, Tomasi D, Wang GJ . Effects of low-field magnetic stimulation on brain glucose metabolism. Neuroimage 2010; 51:623–628.
  • Tepper OM, Callaghan MJ, Chang EI . Electromagnetic fields increase in vitro and in vivo angiogenesis through endothelial release of FGF-2. FASEB J 2004; 18:1231–1233.
  • Macias MY, Battocletti JH, Sutton CH, Pintar FA, Maiman DJ. Directed and enhanced neurite growth with pulsed magnetic field stimulation. Bioelectromagnetics 2000; 21:272–286.
  • Martiny K. Pulsed electromagnetic fields (PEMF) in treatment resistant depression. J Affect Disord 2004; 78:124.
  • Paulus W. Transcranial direct current stimulation (tDCS). Clin Neurophysiol Suppl 2003; 56:249–254.
  • Liebetanz D, Nitsche MA, Tergau F, Paulus W. Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability. Brain 2002; 125:2238–2247.
  • Nitsche MA, Fricke K, Henschke U . Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol 2003; 553:293–301.
  • Nitsche MA, Liebetanz D, Lang N, Antal A, Tergau F, Paulus W. Safety criteria for transcranial direct current stimulation (tDCS) in humans. Clin Neurophysiol 2003; 114:2220–2222; author reply 2222–2223.
  • Paulus W. Transcranial direct current stimulation (tDCS). Clin Neurophysiol Suppl 2003; 56:249–254.
  • Stagg CJ, Nitsche MA. Physiological basis of transcranial direct current stimulation. Neuroscientist 2011; 17:37–53.
  • Fregni F, Boggio PS, Nitsche MA, Marcolin MA, Rigonatti SP, Pascual-Leone A. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord 2006; 8:203–204.
  • Boggio PS, Rigonatti SP, Ribeiro RB . A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol 2008; 11:249–254.
  • Ferrucci R, Bortolomasi M, Vergari M . Transcranial direct current stimulation in severe, drug-resistant major depression. J Affect Disord 2009; 118:215–219.
  • Brunoni AR, Ferrucci R, Bortolomasi M . Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:96–101.
  • Loo CK, Sachdev P, Martin D . A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol 2010; 13:61–69.
  • Bueno VF, Brunoni AR, Boggio PS, Bensenor IM, Fregni F. Mood and cognitive effects of transcranial direct current stimulation in post-stroke depression. Neurocase. 2011; 17:318–322.
  • Galvez V, Alonzo A, Martin D, Mitchell PB, Sachdev P, Loo CK. Hypomania induction in a patient with bipolar II disorder by transcranial direct current stimulation (tDCS). J ECT 2011; 27:256–258.
  • Brunoni AR, Amadera J, Berbel B, Volz MS, Rizzerio BG, Fregni F. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int J Neuropsychopharmacol 2011; 14:1133–1145.
  • Poreisz C, Boros K, Antal A, Paulus W. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull 2007; 72:208–214.
  • Vandermeeren Y, Jamart J, Ossemann M. Effect of tDCS with an extracephalic reference electrode on cardio-respiratory and autonomic functions. BMC Neurosci 2010; 11:38.
  • Boutros NN., Krupitsky EM. Cranial electostimulation therapy. Biol Psychiatry 1998; 43:468–469.
  • Bystritsky A, Kerwin L, Feusner J. A pilot study of cranial electrotherapy stimulation for generalized anxiety disorder. J Clin Psychiatry 2008; 69:412–417.
  • Sackeim HA, Prudic J, Nobler MS . Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul 2008; 1:71–83.
  • Spellman T, Peterchev AV, Lisanby SH. Focal electrically administered seizure therapy: a novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction. Neuropsychopharmacology 2009; 34:2002–2210.
  • Hoy KE, Fitzgerald PB. Introducing magnetic seizure therapy: a novel therapy for treatment resistant depression. Aust N Z J Psychiatry 2010; 44:591–598.
  • Rowny SB, Benzl K, Lisanby SH. Translational development strategy for magnetic seizure therapy. Exp Neurol 2009; 219: 27–35.
  • Dwork AJ, Arango V, Underwood M . Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am J Psychiatry 2004; 161:576–578.
  • Lisanby SH, Moscrip T, Morales O, Luber B, Schroeder C, Sackeim HA. Neurophysiological characterization of magnetic seizure therapy (MST) in non-human primates. Clin Neurophysiol Suppl 2003; 56:81–99.
  • Moscrip TD, Terrace HS, Sackeim HA, Lisanby SH. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). Int J Neuropsychopharmacol 2006; 9:1–11.
  • Lisanby SH, Luber B, Schlaepfer TE, Sackeim HA. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003; 28:1852–1865.
  • Lisanby SH, Morales O, Payne N . New developments in electroconvulsive therapy and magnetic seizure therapy. CNS Spectr 2003; 8:529–536.
  • White PF, Amos Q, Zhang Y . Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anesth Analg 2006; 103:76–80.
  • Spellman T, McClintock SM, Terrace H, Luber B, Husain MM, Lisanby SH. Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biol Psychiatry 2008; 63:1163–1170.
  • Kayser S, Bewernick BH, Grubert C, Hadrysiewicz BL, Axmacher N, Schlaepfer TE. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. J Psychiatr Res 2011; 45:569–576.
  • Sackeim H. Convulsant and anticonvulsant properties of electroconvulsive therapy: towards a focal form of brain stimulation. Clin Neurosci Res 2004; 4:39–57.
  • Borckardt JJ, Linder KJ, Ricci R . Focal electrically administered therapy: device parameter effects on stimulus perception in humans. J ECT 2009; 25:91–98.
  • George MS, Sackeim HA, Marangell LB . Vagus nerve stimulation. A potential therapy for resistant depression. Psychiatr Clin North Am 2000; 23:757–783.
  • Goodnick PJ, Rush AJ, George MS, Marangell LB, Sackeim HA. Vagus nerve stimulation in depression. Expert Opin Pharmacother 2001; 2:1061–1063.
  • Vonck K, De Herdt V, Boon P. Vagal nerve stimulation – a 15-year survey of an established treatment modality in epilepsy surgery. Adv Tech Stand Neurosurg. 2009; 34:111–146.
  • Henry TR, Bakay RA, Votaw JR . Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia 1998; 39:983–990.
  • Rush AJ, George MS, Sackeim HA . Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 2000; 47:276–286.
  • Marangell LB, Rush AJ, George MS . Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002; 51:280–287.
  • Sackeim HA, Rush AJ, George MS . Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001; 25:713–728.
  • Sackeim HA, Brannan SK, Rush JA, George MS, Marangell LB, Allen J. Durability of antidepressant response to vagus nerve stimulation (VNS™). Int J Neuropsychopharmacol 2007; 10:817–826.
  • Corcoran CD, Thomas P, Phillips J, O’Keane V. Vagus nerve stimulation in chronic treatment-resistant depression: preliminary findings of an open-label study. Br J Psychiatry 2006; 189: 282–283.
  • Sackeim HA, Keilp JG, Rush AJ . The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14:53–62.
  • PRNewswire. VNS Therapy® effective at reducing depressive symptoms in patient population experiencing chronic and recurrent treatment-resistant depression: Cyberonics announces data from depression dosing study. Houston, TX. Cyberonics, 2010. [Cited 27 July 2011.] Available from URL: http://ir.cyberonics.com/releasedetail.cfm?ReleaseID = 473897
  • George MS, , Ward HE JrNinan PT . A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul 2008; 1:112–121.
  • Pardo JV, Sheikh SA, Kuskowski MA . Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation. Int J Obes (Lond) 2007; 31: 1756–1759.
  • Borckardt JJ, Anderson B, Andrew Kozel F . Acute and long-term VNS effects on pain perception in a case of treatment-resistant depression. Neurocase 2006; 12:216–220.
  • Benabid AL. Deep brain stimulation for Parkinson's disease. Curr Opin Neurobiol 2003; 13:696–706.
  • Katayama Y, Yamamoto T, Kobayashi K, Oshima H, Fukaya C. Deep brain and motor cortex stimulation for post-stroke movement disorders and post-stroke pain. Acta Neurochir Suppl 2003; 87:121–123.
  • Kupsch A, Kuehn A, Klaffke S . Deep brain stimulation in dystonia. J Neurol 2003; 250:S147–152.
  • Levy RM. Deep brain stimulation for the treatment of intractable pain. Neurosurg Clin N Am 2003; 14:389–399.
  • Rosenow JM, Mogilnert AY, Ahmed A, Rezai AR. Deep brain stimulation for movement disorders. Neurol Res 2004; 26:9–20.
  • Bronstein JM, Tagliati M, Alterman RL . Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011; 68:165.
  • McIntyre CC, Savasta M, Kerkerian-Le Goff L, Vitek JL. Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol 2004; 115: 1239–1248.
  • McIntyre CC, Savasta M, Walter BL, Vitek JL. How does deep brain stimulation work? Present understanding and future questions. J Clin Neurophysiol 2004; 21:40–50.
  • Gouvea F, Lopes A, Greenberg B . Response to sham and active gamma ventral capsulotomy in otherwise intractable obsessive–compulsive disorder. Stereotact Funct Neurosurg 2010; 88:177–182.
  • Lopes AC, Greenberg BD, Noren G . Treatment of resistant obsessive–compulsive disorder with ventral capsular/ventral striatal gamma capsulotomy: a pilot prospective study. J Neuropsychiatry Clin Neurosci 2009; 21:381–392.
  • Nuttin B, Cosyns P, Demeulemeester H, Gybels J, Meyerson B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive–compulsive disorder. Lancet 1999; 354:1526.
  • Nuttin BJ, Gabriels LA, Cosyns PR . Long-term electrical capsular stimulation in patients with obsessive–compulsive disorder. Neurosurgery 2003; 52:1263–72; discussion 1272–1274.
  • Burdick A, Goodman WK, Foote KD. Deep brain stimulation for refractory obsessive–compulsive disorder. Front Biosci 2009; 14:1880–1890.
  • Aouizerate B, Cuny E, Martin-Guehl C . Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive–compulsive disorder and major depression. Case report. J Neurosurg 2004; 101:682–686.
  • Greenberg BD, Malone DA, Friehs GM . Three-year outcomes in deep brain stimulation for highly resistant obsessive–compulsive disorder. Neuropsychopharmacology 2006; 31: 2384–2393.
  • Greenberg BD, Gabriels LA, Malone DA . Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive–compulsive disorder: worldwide experience. Mol Psychiatry 2010; 15:64–79.
  • Denys D, Mantione M, Figee M . Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive– compulsive disorder. Arch Gen Psychiatry 2010; 67:1061–1068.
  • Mayberg HS, Lozano AM, Voon V . Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45:651–660.
  • Kennedy SH, Giacobbe P, Rizvi SJ . Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 2011; 168:502–510.
  • Malone DA, Jr., Dougherty DD, Rezai AR . Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009; 65:267–275.
  • Schlaepfer TE, Cohen MX, Frick C . Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008; 33:368–377.
  • Lagrange E, Krack P, Moro E . Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology 2002; 59:1976–1978.
  • Okun MS, Mann G, Foote KD . Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry 2007; 78:310–314.
  • Fins JJ, Mayberg HS, Nuttin B . Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive–compulsive disorder. Health Aff (Millwood) 2011; 30:302–311.
  • Lefaucheur JP, de Andrade DC. Intraoperative neurophysiologic mapping of the central cortical region for epidural electrode placement in the treatment of neuropathic pain by motor cortex stimulation. Brain Stimul 2009; 2:138–148.
  • Priori A, Lefaucheur JP. Chronic epidural motor cortical stimulation for movement disorders. Lancet Neurol 2007; 6:279–286.
  • Dougherty DD, Thase ME, Howland RH . Feasibility study of an implantable cortical stimulation systems of patients with major depressive disorder. Biol Psychiatry 2008; 63:294S–295S.
  • Nahas Z, Anderson BS, Borckardt J . Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry 2010; 67:101–109.
  • Tyler WJ, Tufail Y, Finsterwald M, Tauchmann ML, Olson EJ, Majestic C. Remote excitation of neuronal circuits using low-intensity, low-frequency ultrasound. PLoS One 2008; 3:e3511.
  • Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 2005; 5:321–327.
  • Carter ME, de Lecea L. Optogenetic investigation of neural circuits in vivo. Trends Mol Med 2011; 17:197–206.
  • Covington HE III, Lobo MK, Maze I . Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci 2010; 30:16082–16090.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.